Is FibroGen Inc (NASDAQ: FGEN) Stock Set To Rise More?

In the last trading session, 4.63 million FibroGen Inc (NASDAQ:FGEN) shares changed hands as the company’s beta touched 0.76. With the company’s per share price at $2.73 changed hands at $0.35 or 14.71% during last session, the market valuation stood at $268.47M. FGEN’s last price was a discount, traded about -808.42% off its 52-week high of $24.80. The share price had its 52-week low at $0.33, which suggests the last value was 87.91% up since then. When we look at FibroGen Inc’s average trading volume, we note the 10-day average is 7.6 million shares, with the 3-month average coming to 1.74.

FibroGen Inc (NASDAQ:FGEN) trade information

Instantly FGEN was in green as seen at the end of in last trading. With action 46.77%, the performance over the past five days has been green. The jump to weekly highs of 2.88 added 14.71% to the stock’s daily price. The company’s shares are showing year-to-date upside of 208.02%, with the 5-day performance at 46.77% in the green. However, in the 30-day time frame, FibroGen Inc (NASDAQ:FGEN) is 223.12% up. Looking at the short shares, we see there were 13.5 million shares sold at short interest cover period of 4.62 days.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

FibroGen Inc (FGEN) estimates and forecasts

Data shows that the FibroGen Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 89.58% over the past 6 months, a 14.01% in annual growth rate that is considerably higher than the industry average of 11.60%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -13.63%. The 2024 estimates are for FibroGen Inc earnings to increase by 16.35%.

FibroGen Inc (NASDAQ:FGEN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 6.21% of FibroGen Inc shares while 70.10% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 74.74%. There are 70.10% institutions holding the FibroGen Inc stock share, with Primecap Management Company the top institutional holder. As of Jun 29, 2023, the company held 13.93% of the shares, roughly 13.68 million FGEN shares worth $36.93 million.

Vanguard Group Inc holds the second largest percentage of outstanding shares, with 9.92% or 9.74 million shares worth $26.3 million as of Jun 29, 2023.

Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Horizon Fund-Capital Opportunity Fund and Primecap Odyssey Aggressive Growth Fund. With 5.19 million shares estimated at $14.0 million under it, the former controlled 5.28% of total outstanding shares. On the other hand, Primecap Odyssey Aggressive Growth Fund held about 3.84% of the shares, roughly 3.77 million shares worth around $7.78 million.

On Key

Related Posts